The sale is pre-planned under a 10b5-1 program, reducing its directional signal. However, the insider has already sold over 417,000 shares in the past two months under the same plan. Monitor for any acceleration of plan sales or changes in insider filing patterns ahead of the next earnings report.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Oct 12 $30.45entry
- T+1 · 5w ago −1.81%α −1.79% · $29.90
- T+5 · 29d ago −2.69%α −1.20% · $29.63
- T+20 · 8d ago +6.83%α +10.10% · $32.53
- T+26 · todayOpen
- T+60 · in 7w Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Ryan A. King, a director and officer of Chime Financial, filed a Form 144 notice of intent to sell 50,000 shares of common stock, with an estimated aggregate market value of approximately $1.45 million. The shares were acquired via previously exercised stock options in 2019, and the filing indicates a 10b5-1 trading plan is in place, with prior plan sales already executed in August and September 2026. While the sale is not large relative to the company's market cap, the insider's dual role and the pre-planned nature of the sale reduce its signaling value.
Key Facts
- Insider: Ryan A. King (Director and Officer)
- Shares to be sold: 50,000 shares of common stock
- Estimated value: ~$1.45 million (based on $28.96/share)
- Shares acquired: 10/10/2019 via exercised stock options
- Sale intended under a 10b5-1 trading plan
- Prior plan sales: 375,000 shares on 08/06/2026 and 42,421 shares on 09/09/2026
- Filing date: 10/09/2026
Financial Impact
~$1.45 million proposed sale by insider; prior plan sales totaled ~$12.85 million in Aug-Sep 2026
Risk Factors
- Insider selling under a 10b5-1 plan is routine, but the cumulative volume (~467,000 shares in ~2 months) may raise questions about insider conviction
- No specific catalyst or earnings date is referenced in the filing
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010144 |
| Document: 0001950047-26-010144-index.html | 0001950047-26-010144 |
| Document: 0001950047-26-010144.txt | 0001950047-26-010144 |
Track record
39 reports on CHYM
9 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +14.85% at T+5 after the Sep 14, 2026 report. 12 of 14 went positive at some point.
Filters
- Nov 17, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 17, 2026today 144 Neutral 2/10 Entry $32.97 Now $32.97 +0.00% settles Nov 25
- Nov 17, 2026today 144 Neutral 3/10 Entry $32.98 Now $32.97 −0.03% settles Nov 25
- Nov 17, 2026today 144 Neutral 2/10 Entry $32.97 Now $32.97 +0.00% settles Nov 25
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 24
- Nov 16, 20261d ago 144 Neutral 3/10 Entry $34.36 Now $32.97 −4.05% settles Nov 24
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $34.36 Now $32.97 −4.05% settles Nov 24
- Nov 13, 20264d ago SC 13G/A Neutral 3/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
- Nov 13, 20264d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
- Nov 13, 20264d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers